Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Skolnick Phil Create: Alert

All | News | Filings
Date FiledTypeDescription
03/03/2023 4 Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.
Txns: Disposed/sold 9,812 shares @ $20, valued at $196.2k
Disposed/sold 11,736 shares @ $20, valued at $234.7k
Granted 2,000 shares @ $0
Disposed/sold 2,000 shares @ $20, valued at $40k
Disposed/sold 40,000 options to buy @ $9, valued at $360k
Disposed/sold 13,200 options to buy @ $13.61, valued at $179.7k
Disposed/sold 8,250 options to buy @ $13.6, valued at $112.2k
Disposed/sold 10,750 options to buy @ $12.15, valued at $130.6k
01/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/09/2023 4 Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.
Txns: Sold 369 shares @ $20.2, valued at $7.5k
01/05/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/27/2022 4 Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.
Txns: Sold 1,518 shares @ $26.19, valued at $39.8k
01/12/2022 4 Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.
Txns: Sold 385 shares @ $30.49, valued at $11.7k
01/05/2022 4 Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.
Txns: Granted 12,000 shares @ $0
01/27/2021 4 Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.
Txns: Granted 2,798 shares @ $0
Granted 5,400 shares @ $0
Granted 10,750 options to buy @ $12.15, valued at $130.6k
01/09/2020 4 Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.
Txns: Sold 2,900 shares @ $13.6, valued at $39.4k
Granted 4,150 shares @ $0
Sold 2,842 shares @ $13.46, valued at $38.3k
Sold 3,043 shares @ $13.36, valued at $40.7k
Granted 8,250 options to buy @ $13.6, valued at $112.2k
01/06/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/06/2019 4 Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.
Txns: Sold 2,057 shares @ $13.74, valued at $28.3k
Sold 800 shares @ $13.34, valued at $10.7k
12/04/2019 4 Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.
Txns: Sold 2,565 shares @ $14.17, valued at $36.3k
Sold 4,578 shares @ $13.93, valued at $63.8k
Exercised 10,000 options to buy @ $9, valued at $90k
11/05/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/03/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/04/2019 4 Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.
Txns: Sold 7,506 shares @ $14.08, valued at $105.7k
Sold 2,494 shares @ $14.37, valued at $35.8k
Exercised 10,000 options to buy @ $9, valued at $90k
08/02/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/02/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/04/2019 4 Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.
Txns: Sold 8,414 shares @ $11.72, valued at $98.6k
Sold 1,586 shares @ $11.63, valued at $18.4k
Exercised 10,000 options to buy @ $9, valued at $90k
05/03/2019 4 Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.
Txns: Sold 8,559 shares @ $11.41, valued at $97.7k
Sold 1,441 shares @ $11.24, valued at $16.2k
Exercised 10,000 options to buy @ $9, valued at $90k
04/03/2019 4 Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.
Txns: Sold 7,993 shares @ $12.71, valued at $101.6k
Sold 2,007 shares @ $12.47, valued at $25k
Exercised 10,000 options to buy @ $9, valued at $90k
03/04/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/04/2019 4 Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.
Txns: Sold 7,768 shares @ $13.84, valued at $107.5k
Sold 2,232 shares @ $13.48, valued at $30.1k
Exercised 10,000 options to buy @ $9, valued at $90k
Granted 13,200 options to buy @ $13.61, valued at $179.7k
12/06/2018 4 Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.
Txns: Sold 1,306 shares @ $15.85, valued at $20.7k
Sold 3,015 shares @ $16.15, valued at $48.7k
Exercised 10,000 options to buy @ $9, valued at $90k
11/08/2018 4 Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.
Txns: Sold 3,217 shares @ $16.81, valued at $54.1k
11/05/2018 4 Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.
Txns: Sold 1,521 shares @ $18.14, valued at $27.6k
Sold 300 shares @ $17.33, valued at $5.2k
Exercised 10,000 options to buy @ $9, valued at $90k
10/04/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/13/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
02/13/2017 3 Form 3 - Initial statement of beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy